Blood Transfusion Meeting Minutes

Blood Transfusion Meeting Minutes

Meeting minutes is to record the basic situation of the meeting, reports, speeches, resolutions and so on, to help us understand the situation in the future. The following is a sample of blood transfusion meeting minutes recommended by me.

Part I: China Blood Transfusion Association, the fourth blood quality management committee 07 annual meeting minutes

First, the meeting briefly:

1, the meeting place: Guiyang City, Guizhou Province, Ramada Fantastic Hotel

2, Duration: November 24-25, 2007

3. Participants: 24 members of the Committee on Blood Quality, attended by 17 people, appointed representatives attended by 2 people, 5 people on leave of absence, 10 people invited. The total number of attendees was 29.

-Members: Zhu Yongming (Vice-Chairman), Zheng Bixian (Vice-Chairman), Li Anli (Vice-Chairman), Tian Changjun, Wang Jun, Zhou Yuan, Hou Pingqin, Wang Ping, Wu Ronggui, Ye Shihui, Liu Zhenqiang, Wang Chuanxi, Chen Lin, Qiu Yan, Li Lixi, Zhai Xiaoping, Xu Zhong (Secretary)

-Replacement of members present: Li Jinming (in place of Shen Ziyu), Luan Yan (in place of Liu Xianzhi)

-Deplacement of members present: Li Jinming (in place of Shen Ziyu), Luan Yan (in place of Liu Xianzhi)

1) Composition of the committee.

2) Committee duties: (adopted by the Fourth Standing Council)

- To assist in the development and revision of national standards for blood quality

- To provide health administrative departments with the development and modification of industry standards

- To conduct research and consulting on the quality of the blood station quality management and quality standards

- To organize the quality of blood management and testing methods, workshops, training courses, experience sharing sessions. Organizing study courses, training courses, and experience exchange meetings

- Recommending members of the committee to participate in practice acceptance as candidates of the expert pool of Practice Acceptance

- Undertaking other related work assigned by the Chinese Blood Transfusion Association (CBTA)

3) Main work accomplished

In accordance with the statute of the Chinese Blood Transfusion Association (CBTA), the Committee on Quality Management of Blood has formulated its management methods and work responsibilities. In addition to organizing the regular annual working meeting (2003-6), the Committee also held quality management seminars with distinctive themes and diverse forms. In accordance with the regulations of the Association, it formulates the annual plan of the Committee, the report on the implementation and completion of the previous year's work, the financial budget, etc., and submits them to the Chinese Blood Transfusion Association.

-November 17-19, 2003 Nanchang, Jiangxi Province:

Members introduced themselves. Discussion of the draft Summary of the Committee's Work in 2003 and the draft Work Plan of the Committee in 2004; members introduced their experiences in carrying out blood quality management in their respective regions, and made comments and suggestions on the future work of the Committee and the Association;

- August 10-11, 2004 Kunming, Yunnan Province:

Regarding the Measures for the Management of Blood Transfusion Stations and the Quality Management of Blood Transfusion Stations Code of Practice for the Management of Blood Stations and the Quality Management of Blood Stations, we widely solicited opinions and submitted the revised drafts to the health administrative department through the Association.

-May 25-26, 2005, Xi'an City, Shaanxi Province

Exchanged information on the implementation of QMP in blood stations across the country; invited relevant legal experts from Beijing and Shanghai to discuss the legal relations related to blood collection and supply, and drafted guidelines for responding to lawsuits in which blood stations are not at fault.

- August 14-15, 2006, Lanzhou City, Gansu Province

Discussed the "Code for Quality Management of Blood Stations/Laboratories", and put forward valuable opinions in the light of the experience of each blood station in the process of learning and implementing the Code, hoping that the health administrative department can further clarify.

- Other

Some members of the Committee participated in the World Health Organization's Quality Management Program (QMP) training courses as faculty members of the Ministry of Health; in the four years from 2003 to 2006, the Committee on Blood Quality and the Shanghai Blood Center co-organized six training courses on the Quality Management System for Blood Transfusion, three of which were held in 2003, and one in each of the years 2004, 2005 and 2006. The total **** collection received nearly 500 students from 23 provinces and cities; February 28, 2006 blood quality committee and Shanghai Blood Center in Shanghai Blood Center web page opened? Quality Q&A? column.

2. Mr. Zhu Yongming, Chairman of the Committee, proposed the topic, agenda, and moderator for this meeting (see below), which was unanimously approved by the participants.

3, Zhu Yongming on behalf of the Blood Quality Committee and the participants of the heartfelt thanks to the leadership of the Guizhou Provincial Blood Center and the relevant comrades for the thoughtful arrangements, and heartfelt thanks to BioMerieh Diagnostic Products Ltd. for the full support of this meeting.

4. Secretary Zeng Min of Guizhou Blood Center made a warm speech, welcoming experts and colleagues from all over the world to come to Guizhou and Guiyang for guidance and exchange.

5, the exchange of their respective blood stations in the implementation of? A law and two regulations? In the experience and confusion (presided over by: Zheng Bixian, vice chairman and member of the Wang Jun)

Fujian Blood Center Guo Yongjian, director of the Shanghai Blood Center Qian Kaicheng, deputy director of the study and implementation respectively? A law and two regulations? The introduction of the speech.

Participants combined with the implementation of their respective units?

For the implementation of?

-How are standards and reagents for QC identified?

- Is the initial reactive specimen retested in the original tube or in a blood bag with blood tubes?

- Should the laboratory, as a subordinate department of the blood station, establish a laboratory quality manual or be part of the quality manual of the blood station

2) What is the role of the central blood station in the? method? There is no blood testing responsibilities, so the issue of authorization of central blood station testing, there should be a rigorous legal interpretation.

3) ? norms? Some of the quantitative provisions (resources, health professionals and professionals professional, qualifications, etc.) of the blood center, central blood stations and other different levels, different business scope (such as whether it is to do blood testing, etc.) of the unit should be appropriately differentiated

4) Strengthening of professional training for the blood station inspection and supervision personnel, it is recommended that the implementation of the qualification system for training and inspection

5) Other recommendations

-Calling on the relevant departments to adapt to the needs of the development of the blood station business, according to the different business conditions and costing in different places, adjust the price of blood, especially the price of plasma at the right time

- In 2006, the Ministry of Health's National Conference on Blood Work called for the strengthening of scientific research on blood, but due to the adjustment of the policy of the new price of blood and other policies, and the lack of clarity in the attribution of the research on blood, the scientific research on blood is far behind the blood collection and supply in terms of both quality and quantity. However, due to the new blood price and other policy adjustments, blood research is not clearly categorized and other issues, the quality and quantity of blood research work around the world are lagging far behind the needs of the development of blood work, and the gap with developed countries is widening.

6. Other technical and managerial issues affecting blood quality and blood safety (Chair: Li Anli)

Wang Chuanxi, Deputy Director of Guangzhou Blood Center, made a presentation on "Blood Deleukocytosis Filtration - Advantages, Benefits, and Opportunities". Blood Deleukocytosis Filtration-Advantages, Preparation, Application and Necessity? The report was introduced by Mr. Yan Lixing, Director of Zhejiang Blood Transfusion Association. Nucleic Acid Detection Technology and its Application in Blood Screening? The Deputy Director of Shanghai Blood Center Office, Mr. Shen Wu, made a presentation on the coding standard of blood collection and supply system. The report of ISBT-128, the coding standard of blood collection and supply system, was made by Mr. Shen Wu, Deputy Director of Shanghai Blood Center Office.

On the basis of the above guiding reports, the participants had an in-depth discussion on some major and urgent issues affecting the blood supply and safety (such as NAT, luminescence and other new blood testing methods, blood de-whitening and filtration, ALT test, blood station information system, etc.), and the meeting reached the **** knowledge as follows:

1) Regarding the blood testing, the meeting held that:

-With the increasing number of Olympic Games, World Expo, and international exchanges, guaranteeing blood safety is not only a medical and social issue, but also a political issue with international influence ;

-NAT is a mature technology, which can shorten the detection? window period?

-NAT is a mature technology that can shorten the testing window period and further improve sensitivity and specificity, and has been widely adopted in developed countries and some neighboring countries and regions for blood donor testing;

-NAT is technically demanding and costly, and a full benefit/cost analysis is necessary for its full-scale promotion;

-Like other access requirements, NAT technology, reagents, and instrumentation should be validated and recognized by national authorities.

- NAT and other emerging and mature assays (e.g., chemiluminescence) should be included in technical protocols as optional blood screening tests, and laboratory quality control strategies and methods should be changed accordingly;

- Pilot testing in some domestic blood centers has identified enzyme-negative/nucleic acid-positive blood specimens;

- Current regulatory policies, such as blood pricing, have inhibited the introduction of NAT into the blood market. The current management policy of blood price has inhibited the enthusiasm of blood stations to research and explore the adoption of new blood safety technologies, which is not conducive to the further improvement of blood safety;

It is hoped that the relevant departments will organize/coordinate the research on the necessity and feasibility of introducing NAT and luminescence into the protocols as soon as possible, and make conclusions that are in line with the reality of the domestic work of blood supply and the improvement of blood safety.

2) About ? Deleukocyte filtration (white filter)? Some provincial health administrations in China have already prohibited hospitals from filtering, which is worth summarizing and promoting;

-The quality control standards of filtering should be clear and based on the validation of filtering equipment and filtering effect;

-The filtering technology and consumables must be validated and approved by the national authority;

-The current management policy on blood price has hindered the implementation of comprehensive filtering in the blood stations, which is not conducive to the further improvement of blood safety.

3) Regarding ?ALT test? Experts suggest that the screening model for blood donors should be adjusted, e.g., testing for ALT before blood collection can indeed reduce the rate of blood scrapping, but it is not suitable as a nationally standardized blood-testing strategy because of the inability to standardize and the difficulty of quality control. It is recommended that a standardized interval for ALT testing that is responsible for both donors and recipients be determined through scientific design and extensive statistical data).

It is hoped that the relevant departments will organize/coordinate a study on the necessity and feasibility of the above issues as early as possible, and make conclusions that are in line with the reality of the domestic blood collection and supply work and the improvement of blood safety

4) With regard to the unification of the ?MIS information coding? ISBT-128 is supported by most of the international mainstream computer, blood collection equipment and consumables manufacturers, and has been formally adopted by more than 60 countries and regions around the world, including developed countries in Europe and the United States. The adoption of ISBT-128 requires the payment of maintenance fees, but is within the acceptable range of domestic blood stations. (Annual blood collection of 10,000 units is about RMB 500 yuan)

- At present, there are various information codes in China, and quite a number of them are? A considerable number of them are based on the ISBT-128 code. It is hoped that the relevant departments will organize/coordinate the research on the necessity of unification of information coding standards, and how to unify them, so as to avoid the potential huge waste of the development of information systems in different places, and to improve the level of blood management, blood safety, and the ability to cope with emergency incidents. The China Blood Transfusion Association (CBTA) recommended ISBT128 as the information coding standard for blood stations in its 2006 work plan, and the QAC recommends that domestic blood stations should actively consider registering as ISBT128 users to legally use this standard when the domestic standard has not yet been unified and to enjoy the due rights such as technical services, field protection, and so on, in a timely manner.

7. Zhu Yongming summarized the meeting and asked the secretariat of the Committee to compile the minutes of the meeting in a timely manner, and asked all the participants to revise them and submit them to the China Blood Transfusion Association in a timely manner, which would then hand them over to the relevant health administrations.

8. Zhu Yongming, on behalf of China Blood Transfusion Association, thanked the members of the four blood quality committee for their work, and on behalf of the secretariat of the blood quality committee, thanked Guizhou Blood Center for the work done for the meeting, and thanked all of you for your active participation, as well as constructive discussion, which made the work of this session of the blood quality committee can be completed successfully and smoothly.

9. The meeting was adjourned.

China Blood Transfusion Association Blood Quality Management Committee Secretariat

November 2, 2007

Part II: convene a meeting of the Blood Transfusion Management Committee

June 21, in the office building on the second floor of the conference room, held a meeting of the Blood Transfusion Management Committee, the members of the Blood Transfusion Management Committee, in addition to Li Wupeng all attended the meeting, the meeting was held by Liu Qingping, a member of the Blood Transfusion Management Committee. All members of the Transfusion Management Committee except Li Wenping attended the meeting, which was presided over by Vice President Liu Qinghua.

First of all, the director of blood transfusion, Fu Daoyong reported on the first half of 2014 clinical blood situation: *** counted 1035 transfusions, including transfusion of red blood cells 1967 u, plasma 1137 ml, 198 bags of cold precipitation, platelets, 42 therapeutic amount of blood, the proportion of component blood 100%. The total blood used was 3,343 units (including u, ml, bags and therapeutic volume), compared with the same period last year, the year-on-year growth rate was 3.35%, analyzing the main reason is that the number of patients in 2014 increased significantly compared with the same period last year. All clinical departments strictly grasp the transfusion indications, the use of blood is more reasonable; blood transfusion application form filled out standardized. Over the past six months, only one case of adverse reactions to blood transfusion occurred, a patient in the gynecology department in the transfusion of itchy skin, scattered rash, relieved by symptomatic treatment, after investigation, the transfusion department in the cross-matching, issue of blood and clinical departments in the process of transfusion of blood are not improper operation, analysis of the reasons for the consideration of the patient's body type related to the occurrence of transfusion of allergic reactions; a large number of transfusion of blood (24-hour transfusion & gt; 1600 ml), a large number of transfusion of blood. For general surgery patients, due to compound trauma caused by hemorrhagic shock, the application of red blood cells 12 u, plasma 1000 ml, platelets two therapeutic volume, cold precipitation 20 bags, transfusion of blood before the clinical department is also in accordance with the provisions of the transfusion management, fill out the "large amount of blood transfusion application form" reported to the medical department for approval.

Subsequently, the members of the meeting combined with the actual work, respectively, in the hospital clinical blood transfusion management found in the problem report, and actively discuss, put forward reasonable suggestions.

Director Zhang Tianting, vice chairman of the Blood Transfusion Management Committee, emphasized that blood transfusion therapy, as one of the clinical therapies, is widely used, and the quality of blood transfusion work has an increasingly large impact on the quality of medical care in hospitals, and that clinical blood transfusion is a therapeutic task that involves medical, medical technology, and nursing personnel successively, and is completed by the same staff, and that negligence or non-standardized operation of any one part of the process may affect the treatment and even have serious consequences. Any negligence or non-standard operation may affect the blood transfusion treatment and even produce serious consequences. Therefore, the management of blood transfusion in hospitals is always facing a great challenge, and it is necessary to strictly implement the "Clinical Blood Transfusion Technical Code" and the "Measures for the Administration of Blood in Medical Institutions" to ensure the safety of blood transfusion in the clinic. The overall quality is better through the standardized training of the preliminary second A standard assessment. However, there are still deficiencies: such as some departments, individual cases of clinical blood transfusion records are not standardized; the number of reported cases of adverse reactions to clinical blood transfusion is too small, is there no adverse reactions? Is it because there is no adverse reaction? Or is it because of omission? Blood transfusion department lacks the initiative to participate in blood transfusion quality management awareness, should take the initiative to clinical departments to guide the use of blood, more clinical departments to use more blood to review the use of blood is clear, whether the use of blood is standardized and reasonable; at the same time, the future conditions should be created, and actively carry out new business such as autologous transfusion, and actively carry out the dissemination of knowledge of blood transfusion. Subsequently, the Nursing Department and other functional departments introduced their own blood transfusion management found in some of the problems, and put forward specific recommendations for improvement.

Finally, Vice President Liu Qinghua, Chairman of the Blood Transfusion Management Committee, summarized the meeting. First of all, she fully recognized the clinical blood transfusion management of the relevant functional departments, and put forward three requirements for the future clinical blood transfusion management in the hospital: 1) we should continuously learn new knowledge and do a good job of training new personnel in clinical blood use laws and regulations and related systems; 2) the personnel of the Laboratory Department and the Transfusion Department should do a good job of laboratory tests; nursing personnel should be able to implement a variety of operating procedures, and do a good job of observation and nursing care in order to Reduce or avoid the danger of blood transfusion treatment. 3, to strengthen the exchange and communication, standardize clinical blood transfusion, improve the quality of medical services; 4, strictly in accordance with the rules and regulations, standardize medical behavior, clinical blood transfusion should be grasped? Clinical blood transfusion should grasp the principle of "no transfusion, no transfusion, less transfusion, less transfusion". The clinical blood transfusion should grasp the principle of "no transfusion if it can be avoided, and less transfusion if it can be minimized", and should effectively control the amount of clinical blood used, as well as use blood in a reasonable, safe and effective way to meet the clinical blood demand, guarantee the safety of clinical blood transfusion, and provide good services for clinics and patients. At the same time, especially put forward the requirements of the transfusion department: 1, strengthen the awareness of transfusion adverse reactions reported in a timely manner; 2, pay attention to the importance of safe issuance and testing, do a good job of clinical blood registration, strengthen the transfusion of blood visit work, the establishment of an adverse reaction registry, do a good job of summarizing the shortcomings of the rectification; 3, according to the actual situation, and actively carry out new business, to meet the needs of the clinical work.

;